50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Our mission is to design, develop, manufacture and market advanced implantable neuromodulation devices that improve the quality of life for people suffering from chronic intractable pain and other disorders of the nervous system.”In use 2005 – now·1 sighting·SEC Form 10-K, filed 2005-03-1564% match
“Our mission is to revolutionize regenerative medicine by bioengineering patient-specific Cellspan implants that use the patient’s own mesenchymal stromal cells to stimulate organ regeneration and restore an organ’s structure and continuity.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-04-1363% match
“Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-02-1863% match
“Our mission is to develop sustainable rehabilitation solutions, particularly for degenerative diseases, ensuring that our products not only address current symptoms but also support future, long-term health and recovery.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2761% match
“Our mission is to advance drug-free neuromodulation therapies that improve patient outcomes and reduce medication burden in complex disorders, while expanding access to effective care for populations with significant unmet needs.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1961% match
“Our mission is to use technology to enhance the gift of life and to develop therapy-driven products that alleviate pain, promote biological healing and restore function.”In use 2007 – now·1 sighting·SEC Form 10-K, filed 2007-03-1461% match
“Our purpose is to innovate to bring therapies to patients that significantly improve their lives.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1361% match
“Our mission is to discover and develop novel therapeutics to improve the lives of patients living with debilitating CNS disorders.”In use 2025 – now·1 sighting·SEC Form S-1/A, filed 2025-10-0660% match
“Our mission is to develop therapies that empower the immune system to cure neurodegeneration and other diseases.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-02-2760% match
“Our mission is to develop and license novel stem cell synthetic hydrogel-based solutions and systems to repair and regenerate neuronal damage.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-03-3060% match
“Our mission is to reduce the impact of neurological disorders and pain syndromes on individuals and on population health through innovative non-invasive medical devices.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-01-2860% match
“Our mission is to make life better by transforming mobility.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-06-3060% match
“Our mission is to improve the lives of patients suffering from CNS diseases.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0260% match
“Our mission is to restore active living, empower surgeon choice, and enhance patient outcomes worldwide.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0360% match
“Our mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.”In use 2015 – now·1 sighting·SEC Form S-1, filed 2015-07-2460% match
“Our mission is to restore these neuronal networks and, in turn, personal connections by advancing bold therapies for neuronal health, thoughtfully and urgently.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-02-2259% match
“Our mission is to redefine the life of the SCI patient, and we seek to develop treatment options intended to provide meaningful improvement in patient outcomes following SCI.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-0159% match
“Our mission is to use our technology to create a new generation of RNAi therapeutics which can improve outcomes for patients.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-09-0859% match
“Our mission is to develop, license and acquire non-invasive treatments designed to help patients affected by neurological symptoms caused by disease or trauma.”In use 2016 – now·1 sighting·SEC Form 10-K/A, filed 2016-11-0159% match
“Our mission is to transform the treatment of rare diseases and expand the availability of transplantable organs through innovative organ manufacturing technologies.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2559% match
“Our mission is to team with clinicians to advance innovative device therapies that modulate the ANS to meaningfully improve the lives of people with chronic disease.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1359% match
“Our mission is to enable patients with these disorders to live fuller and healthier lives through the discovery and development of transformative therapies that overcome the key limitations of currently available treatments.”In use 2026 – now·1 sighting·SEC Form 424B4, filed 2026-08-1258% match
“Our mission is to improve the quality of life for patients with missing teeth by providing dental professionals with innovative, evidence-based dental implants and biologics products.”In use 2011 – now·1 sighting·SEC Form S-1/A, filed 2011-01-1858% match
“Our mission is to redefine stroke recovery for survivors living with life-altering functional impairments by establishing Vivistim Therapy as the standard of care for chronic stroke.”In use 2026 – now·1 sighting·SEC Form 424B4, filed 2026-05-0858% match
“Our mission is to develop disease-modifying, regenerative therapies to restore vision to millions of patients.”In use 2025 – now·1 sighting·SEC Form S-1, filed 2025-01-2458% match
“Our mission is to improve, extend and save lives by advancing innovative micromedical technologies through joint development and manufacturing partnerships with industry leading medical device companies.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-0758% match
“Our mission is to apply advances in neuroscience and cognitive research to increase human potential.”In use 2003 – now·1 sighting·SEC Form 10-K, filed 2003-03-3158% match
“Our mission is to improve people’s brains.”In use 2023 – now·1 sighting·SEC Form S-1/A, filed 2023-10-2058% match
“Our mission is to Lift Lives by improving the appearance and quality of life of patients using clinically established, safe and effective technologies.”In use 2014 – now·1 sighting·SEC Form S-1/A, filed 2014-06-0258% match
“Our mission is to discover, develop, and deliver novel, life-transforming therapies to people suffering from rare, severe, and devastating neuromuscular diseases.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0358% match
“Our mission is to improve the lives of people touched by epilepsy, depression and other chronic disorders that may prove to be treatable with our VNS Therapy System.”In use 2007 – now·1 sighting·SEC Form 10-K, filed 2007-07-0658% match
“Our mission is to provide innovative solutions that empower patients to confidently take control of their medical conditions.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-02-2258% match
“Our mission is to develop innovative therapies that can transform patients' lives by addressing areas of high unmet medical need.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2358% match
“Our mission is to continuously improve the outcomes and experiences of patients suffering from foot and ankle conditions, and we operate under the following principles: inclusion and respect of individual surgeons’ preferences, creative innovation, high-quality, cost-effective implants, and a strong belief that through research and innovation, we can create new and improved solutions to the challenges faced by foot and ankle specialists.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-0658% match
“Our mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients suffering from brain diseases.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-0757% match
“Our mission is to deliver transformative therapeutics to those in need, and we believe our innovative EDO technology is well-positioned to effect this change for patients, families and the broader healthcare community.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0457% match
“Our mission is to provide transformative therapies to patient communities who have inadequate or no therapeutic options available to address these debilitating diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-0857% match
“Our mission is to become the recognized global leader in restoring spinal function through minimally invasive therapies.”In use 2007 – now·1 sighting·SEC Form 10-K, filed 2007-02-2857% match
“Our mission is to develop, manufacture and distribute worldwide visual implants and other ophthalmic products that improve the vision of patients with cataracts, refractive conditions and glaucoma.”In use 2005 – now·1 sighting·SEC Form 10-K/A, filed 2005-04-2157% match
“Our mission is to improve global wellness for people suffering from various painful conditions by relieving chronic and acute pain using energy, frequency, and vibration as an alternative to pharmaceuticals and that one day, read and modify electrical signals passing along nerves in the body, to restore long-term health.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-05-0157% match
“Our mission is to develop and produce innovative, life-changing technologies to enable patients to become their ‘best possible self’, in the safest and most effective manner.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-02-1057% match
“Our mission: Eliminate the organ transplant waiting list We are a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-06-2457% match
“Our mission is to advance to market novel regenerative medicine and cellular therapy products that substantially benefit humankind.”In use 2016 – now·1 sighting·SEC Form S-1/A, filed 2016-02-0257% match
“Our mission is to empower physicians globally to deliver the transformative benefits of regenerative medicine—stem cell therapies, exosomes, peptides, and advanced combination protocols—to patients seeking effective, natural alternatives to traditional surgical, palliative, or symptom-management approaches.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-05-1457% match
“Our mission is to revolutionize BPH treatment globally in partnership with urologists by delivering best-in-class robotic solutions that positively impact patients and drive value.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2657% match
“Our mission is to use intelligent systems to connect technological innovation with practical applications and to provide individuals, institutions, and commercial organizations with technology-enabled solutions in healthcare, rehabilitation, general wellness management, and related fields.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-05-1157% match
“Our mission is to create disease-modifying neurogenetic medicines by identifying validated targets, advancing multiple therapeutic modalities, and delivering them to the right areas within the central nervous system.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1157% match
“Our mission is to develop and commercialize innovative medicines that change the course of the disease in patients who suffer from age-related brain disorders.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1357% match
“Our mission is to improve patient outcomes in the areas of neurodegenerative and oncological diseases by developing safe and effective cellular therapies that leverage the power of a patient’s immune system.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-10-0857% match
“Our mission is to develop transformative medicines to improve the lives of patients with central nervous system (CNS) disorders, such as Tuberous Sclerosis Complex (TSC)-related epilepsy and other diseases associated with dysregulation or overexpression of filamin A. Our science is based on modulating the activity of a critical protein in the brain for patients with certain CNS disorders, such as TSC.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1256% match
Showing 1–50 of 50